Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00657371 · ClinicalTrials.gov registry record · NA
Efficacy of the Third Eye Retroscope Auxiliary Imaging System
A NA study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 288
- Enrollment target
NCT00657371: Completed NA study, sponsored by M.D. Anderson Cancer Center.
NCT00657371 is a NA study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 288 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00657371, a NA study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 288 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate efficacy of the Avantis Third Eye Retroscope auxiliary imaging system. The primary objective of this study is to assess the degree to which incorporating the Third Eye Retroscope auxiliary imaging system in a screening colonoscopy setting results in the detection of additional polyps. Specifically, the primary goals are to estimate (1) the proportion of polyps detected under this protocol that would have been missed without the Third Eye Retroscope, and (2) the proportion of patients found under this protocol to have polyps who would have incorrectly been classified as polyp-free had the Third Eye Retroscope not been used.
Interventions
- DEVICE Third Eye Retroscope Auxiliary Imaging System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 288 participants |
| Start Date | 2008-03 |
| Est. Completion | 2010-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00657371
The ClinicalTrials.gov registry entry for NCT00657371 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 288 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Third Eye Retroscope Auxiliary Imaging System is the first listed.
NCT00657371 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00657371 about?
NCT00657371 is a clinical study titled "Efficacy of the Third Eye Retroscope Auxiliary Imaging System". The purpose of this study is to demonstrate efficacy of the Avantis Third Eye Retroscope auxiliary imaging system. The primary objective of this study is to assess the degree to which incorporating the Third Eye Retroscope auxiliary imaging system in a screening colonoscopy setting results in the d...
What is the current status of trial NCT00657371?
This trial is currently completed. It is a NA study. The enrollment target is 288 participants. The study started on 2008-03. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00657371?
The interventions under investigation include: Third Eye Retroscope Auxiliary Imaging System (DEVICE).
Who is sponsoring clinical trial NCT00657371?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.